Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot-Assisted hysterectomy shows promise in small trial

NCT ID NCT06473675

Symptom relief Sponsor: Distalmotion SA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the safety and effectiveness of the DEXTER robotic system in 52 patients having a hysterectomy (removal of the uterus) and related surgery for non-cancerous conditions. The main goals were to see if the robotic procedure could be completed without switching to open or standard laparoscopic surgery, and to track any serious complications. The results help confirm whether this robotic tool is a reliable option for these surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

52 people

The number who actually took part.

Started

Jun 2024

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients undergoing a hysterectomy with adnexal surgery for benign disease.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged \> 18 years * Patients planned to undergo elective robot-assisted and laparoscopic hysterectomy with adnexal surgery for benign disease; using one camera port, two ports for the manipulating instruments, and additional ports as needed. Exclusion Criteria: * Morbidly obese patients (BMI \> 40) * Any relative and absolute contraindications for the use of conventional endoscopes and endoscopic surgical instruments * Need for robotic stapling, advanced energy delivery, ultrasound, cryoablation and microwave energy delivery * Bleeding diathesis * Pregnancy * Patients with pacemakers or internal defibrillators * Any planned concomitant procedures * Patient deprived of liberty by administrative or judicial decision. * Participation in another interventional clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign uterine disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

uterine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hysterectomy

Contacts and locations

Locations

  • Groupe Hospitalier Saintes - Saint-Jean-d'Angély

    Saintes, 17100, France

  • Inselspital Bern

    Bern, Switzerland

  • Kantonsspital Baden

    Baden, Switzerland

  • Spitäler FMI AG

    Interlaken, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.